Paul Kirchgraber

Paul currently serves on the Board of Directors of CELLTREAT Scientific Products. He is also serves as an Independent Director at KCAS Bio Bioanalytical Services. He was formerly an Independent Director at Flagship Biosciences and MLM Medical Labs. Paul was CEO of Labcorp Drug Development (f.k.a. Covance), a $6 billion contract research organization, where he led global clinical trial and laboratory services across five continents.  He is Past Chairman of the Association of Clinical Research Organizations